Thyroid Cancer And Other Thyroid Disorders An Issue Of Endocrinology And Metabolism Clinics Of North America

This issue of Endocrinology and Metabolism Clinics, guest edited by Dr. Michael Mingzhao Xing, is dedicated to Thyroid Cancer. Topics include, but are not limited to, Current Histological Classification of Thyroid Cancer, Molecular Pathogenesis and Mechanisms of Thyroid Cancer, Clinical Diagnostic Evaluation of Thyroid Nodules, Molecular Diagnostic Evaluation of Thyroid Nodules, Clinical Risk Stratification of Differentiated Thyroid Cancer, Molecular Risk Stratification of Differentiated Thyroid Cancer, Conventional Thyroidectomy in the Treatment of Primary Thyroid Cancer, Neck Dissection in the Surgical Treatment of Thyroid Cancer, Conventional Robotic Endoscopic Thyroidectomy for Thyroid Cancer, Transoral Endoscopic Thyroidectomy for Thyroid Cancer, Conventional Radioiodine Therapy for Differentiated Thyroid Cancer, Re-differentiation of Radioiodine-refractory Thyroid Cancer for Radioiodine Treatment, Management of Papillary Thyroid Microcarcinoma, Conservative Surveillance Management of Low-risk Papillary Thyroid Microcarcinoma, Thyroid-stimulating Hormone Suppression Therapy in Differentiated Thyroid Cancer, Diagnostic Imaging Testing in the Surveillance of Thyroid Cancer Recurrence, Novel Drug Treatments of Progressive Radioiodine-refractory Differentiated Thyroid Cancer, Management of Anaplastic Thyroid Cancer, and Management of Medullary Thyroid cancer.

This issue of Medical Clinics of North America provides the latest essential updates on thyroid disorders and diseases. Topics covered include the following: thyroid synthesis and physiology; hyperthyroidism; hypothyroidism; thyroid nodules; goiter; differentiated thyroid cancer; subacute, silent, and postpartum thyroiditis; thyroid and pregnancy; thyroid and the elderly; medications and thyroid hormones; thyroid and the heart; thyroid and lipids; and Graves’ ophthalmology.

This issue of Endocrinology and Metabolism Clinics, Guest Edited by Dr. Mark E. Molitch, will focus on Pregnancy and Endocrine Disorders. Topics include, but are not limited to, Gestational Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Hyperthyroidism, Hypothyroidism, Thyroid Nodules, Thyroid Cancer, Thyroiditis, Pituitary Tumors, Pheochromocytoma, Congenital adrenal hyperplasia, Adrenal Insufficiency, and Calcium/Vitamin D Disorders.

This issue of Endocrinology and Metabolism Clinics will cover Pediatric Endocrinology. Curated by Dr. Andrea Kelly, this issue will explore topics in the field that are relevant for practicing clinicians. This issue is one of four selected each year by the series Consulting Editor, Adriana G. Ioachimescu. The volume will include articles on: Endocrine Sequelae in Childhood Cancer Survivors, Bone Health in Childhood Chronic Disease, Advances in Bone Health Assessment, Inhaled Glucocorticoids and Endocrine Outcomes, Atypical DM (mitochondrial, transplant, CFRD, monogenic), Pediatric Thyroid Cancer (outcomes, genetics, therapeutics), New Technologies in Type 1 diabetes (bionic pancreas, insulin, mobile health), Precocious and Delayed Puberty—Genetic Underpinnings and treatments (various GNRH formulations, implant), Pediatric Type 2 diabetes, Adolescent health outcomes in relation to phthalates.

In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Megan R. Haymart and Maria Papaleontiou bring their considerable expertise to the topic of Thyroidology. Top experts in the field cover recent advances in the diagnosis and management of thyroid conditions, providing a contemporary view of updates in this challenging field. Contains 12 relevant, practice-oriented topics including disparities in thyroid care; the use of LT4/LT3 combinations in treating hypothyroidism; minimally invasive procedures for thyroid nodules; less intensive management options for low-risk thyroid cancer; and more. Provides in-depth clinical reviews on thyroidology, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This issue of Endocrinology and Metabolism Clinics, guest edited by Drs. Richard Auchus, Adina Turcu, Alan D. Waxman, and Barry D. Pressman, is devoted to Biochemical and Imaging Diagnostics in Endocrinology. Articles in this issue include Mass spectrometry applicability in endocrine testing; Point-of-care endocrine testing; Thyroid, Bone; NET; Predictors of fertility; Thyroid ultrasound imaging and needle biopsy; Pituitary imaging; Adrenal imaging; Pancreatic imaging; Diagnosis and management of thyroid disorders; Neuroendocrine Tumors, and Parathyroid Imaging.

Managing and treating patients with thyroid issues accounts for about 30% of an endocrinologist’s practice. The issue will be divided into two parts: thyroid cancer and other major disorders. Articles will cover new information on TSH and radioiodine therapy to treat thyroid cancer, as well as best practices for managing hypothyroidism, Graves disease and thyroiditis.

Thyroid disorders are significant, common health problems affecting many people all over the world. Subclinical thyroid disease affects as many as 10% of the population in the United States. Incidence of thyroid cancer, compared to cancer incidence as a whole, is increasing at a steady rate. There have been numerous recent advances in diagnosis and treatment for thyroid disorders. This essential issue of the Endocrinology and Metabolism Clinics of North America presents and clarifies the most important and current topics of concern regarding thyroid assessment and management of related diseases and disorders. Topics covered include the latest thyroid function tests, thyroid and bone, nodules, cytology, thyrotoxicosis, and hypothyroidism. The most important topics in thyroid cancer are also covered, including cancer in children, molecular signaling and use of targeted agents, papillary thyroid cancer, medullary thyroid cancer, anaplastic thyroid cancer, and radioactive iodine treatment.